We observe that the MDS patients are older on average (67.42 vs. 62.53 years of age) and have a delayed PD onset (59.23 vs. 54.50 years of age), as compared to the LRRK2 patients; this was also reflected in the demographic characteristics for all the subtypes. The gene discussed is LRRK2; the disease is myelodysplastic syndrome.